Introduction of the Designer Anabolic Steroid Control Act of 2014 (DASCA) by Senators Orrin Hatch (R-Utah) and Sheldon Whitehouse (D-RI) has been welcomed by key industry stakeholders.
The Designer Anabolic Steroid Control Act of 2014 emphasizes on ensuring that anabolic androgenic steroids are not misrepresented as legitimate dietary supplements by broadening the definition and imposing tougher penalties on firms making and selling these potent drugs. DASCA also seeks to amend the Controlled Substances Act for adding more than twenty-five new substances to current lists of defined anabolic steroids besides revising the process whereby new substances can be added in future. This act also creates penalties up to $2.5 million and up to 10 years in prison for the manufacture, sale and/or distribution of substances that meet the definition.
Travis Tygart, CEO of the US Anti-Doping Agency (USADA), welcomed the legislation and remarked the legislation introduced today by Senators Hatch and Whitehouse is an important step in helping to protect athletes at all levels, parents and all consumers from unscrupulous companies who are selling dangerous designer steroids disguised as supplements. Tygart added we as part of our mission for clean athletes work to help athletes understand the risks associated with supplement use, and we look forward to continuing to work with our Congressional leaders as they help ensure that the laws of this country can safeguard the public.
The 2014 bill is a re-introduction of the 2012 bill of the same name that was introduced in 2012 by Senators Hatch and Whitehouse but failed to become a law. Mike Greene, VP of government relations for the Council for Responsible Nutrition (CRN), said there were a lot of confounding issues that occurred in 2012 and added a lot of bills didn’t pass in that year. Whether that was due to bipartisan or political reasons, we don’t know, but we are very hopeful that it will pass this time. Greene also said if you look at the warning letters from the FDA over the last four years, you’ll see that anabolic steroids falsely marketed as dietary supplements continue to be an issue and went on to remark that there is still a way to go before it becomes law.
Introduction of the Act was also welcomed by a joint statement from the American Herbal Products Association (AHPA), the Consumer Healthcare Products Association (CHPA), the Council for Responsible Nutrition (CRN), the Natural Products Association (NPA) and the United Natural Products Alliance (UNPA). The statement read that the trade associations of the dietary supplement industry strongly support DASCA, a bill that protects consumers by empowering the Drug Enforcement Administration (DEA) with new tools to identify and quickly respond when new designer anabolic steroids—illegal drugs—are falsely marketed as dietary supplements. It also read that DASCA will place new anabolic steroids on the DEA Controlled Substance List, and will change the criteria for placing additional anabolic steroids on the list going forward and among the improvements brought about by DASCA will be new guidelines for DEA to address products that are ‘substantially similar’ to anabolic steroids and that have been illegally marketed to promote muscle growth.